Methylhexanamine

Methylhexanamine (commonly known as 1,3-dimethylamylamine or DMAA) is a stimulant drug of the amphetamine class. It was originally used as a nasal decongestant in the 1940s but has since been widely used as a dietary supplement and performance-enhancing drug.

History

Methylhexanamine was first synthesized and patented by Eli Lilly and Company in the 1940s for use as a nasal decongestant. It was sold under the trade name Forthane to treat conditions such as rhinitis, hay fever, and other allergic reactions. However, it was withdrawn from the market due to side effects and the development of more effective and safer drugs.

Uses

In the 21st century, methylhexanamine found a new use as a dietary supplement and performance-enhancing drug. It is often included in pre-workout and weight-loss supplements due to its stimulant effects. It is believed to increase energy, focus, and metabolic rate, although these claims are not supported by scientific evidence.

Health Risks

The use of methylhexanamine is associated with several health risks. It can cause a rapid heartbeat, high blood pressure, and other cardiovascular problems. It has also been linked to several deaths and acute liver failure. As a result, it has been banned by many sports organizations and health authorities worldwide.

Legal Status

Methylhexanamine is banned by many sports organizations, including the World Anti-Doping Agency and the National Collegiate Athletic Association. It is also illegal in several countries, including the United States, Canada, and the United Kingdom.

See Also

• Amphetamine
• Dietary supplement
• Performance-enhancing drug

References

Methylhexanamine Resources
Latest articles Most recent articles Ongoing trials	Wikipedia